What Pulmatrix Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Iwicki Mark T | Director | Apr 03 | Open-market buy · P | +307,000 | — | — | 307,000 |
| Gillis Steven | Director | Apr 03 | Open-market buy · P | +1,150,000 | — | — | 3,436,456 |
| Sherman Matthew L | Director | Apr 03 | Open-market buy · P | +20,000 | — | — | 20,000 |
| Mcguire Terrance | Director | Apr 03 | Open-market buy · P | +7,700 | — | — | 34,587 |
| Mcguire Terrance | Director | Apr 03 | Open-market buy · P | +5,275 | — | — | 23,875 |
| Mcguire Terrance | Director | Apr 03 | Open-market buy · P | +15,007 | — | — | 67,729 |
| Mcguire Terrance | Director | Apr 03 | Open-market buy · P | +769,989 | — | — | 3,468,190 |
| Mcguire Terrance | Director | Apr 03 | Open-market buy · P | +6,478 | — | — | 29,178 |
| Mcguire Terrance | Director | Apr 03 | Open-market buy · P | +345,551 | — | — | 1,556,676 |
| Clarke Robert W. | Chief Executive Officer | Mar 22 | Exercise / conversion · M | +4,525 | $2.21 | +$10K | 4,525 |
| Hava David L. | Chief Scientific Officer | Mar 22 | Exercise / conversion · M | +2,263 | $2.21 | +$5K | 2,263 |
| Oculus Innovative Sciences, Inc. | 10% owner | Jun 17 | Open-market sale · S | −922,500 | $2.75 | −$2.54M | 0 |
| Oculus Innovative Sciences, Inc. | 10% owner | Jun 16 | Open-market sale · S | −727,500 | $2.75 | −$2M | 922,500 |
| Clarke Robert W. | Chief Executive Officer | Jun 15 | Grant / award · A | +18,667 | — | — | 18,667 |
| Hava David L. | Chief Scientific Officer | Jun 15 | Grant / award · A | +4,863 | — | — | 4,863 |
| Mcguire Terrance | Director | Jun 15 | Open-market buy · P | +1,392 | $6.88 | +$9.57K | 52,722 |
| Mcguire Terrance | Director | Jun 15 | Open-market buy · P | +715 | $6.88 | +$4.92K | 26,887 |
| Mcguire Terrance | Director | Jun 15 | Open-market buy · P | +490 | $6.88 | +$3.37K | 18,600 |
| Mcguire Terrance | Director | Jun 15 | Open-market buy · P | +71,439 | $6.88 | +$491K | 2,698,201 |
| Oculus Innovative Sciences, Inc. | 10% owner | Mar 23 | Open-market sale · S | −350,000 | $2.75 | −$963K | 1,650,000 |
Loading...